Aging is now understood as a set of distinct, interconnected biological processes, called the hallmarks of aging, rather than a single mechanism, and different compounds target different hallmarks. NAD+ precursors support declining cellular energy metabolism, spermidine triggers autophagy (cellular cleanup), fisetin and related compounds may clear senescent "zombie" cells, and Urolithin A supports mitophagy, the clearance of damaged mitochondria. None of these reverse aging outright, but each has a genuine, distinct mechanistic rationale and a growing, if still early, human evidence base.
Quick Facts
- Core concept: Aging involves multiple distinct hallmarks, not one single mechanism
- NAD+ precursors: Address declining cellular energy metabolism
- Spermidine: Triggers autophagy, the cell's self-cleaning process
- Fisetin: A senolytic candidate, clearing senescent cells, in early human trials
- Urolithin A: Supports mitophagy, clearance of damaged mitochondria
The Hallmarks of Aging Framework
Modern aging biology organizes the aging process into a set of distinct, interconnected hallmarks, including cellular senescence, mitochondrial dysfunction, loss of proteostasis (protein quality control, closely tied to autophagy), and epigenetic alterations. This framework matters practically because it explains why no single compound is likely to be a complete "anti-aging" solution; different compounds address different hallmarks, and a thoughtful approach considers which ones a given intervention actually targets.
NAD+ Precursors: Cellular Energy Metabolism
NAD+, required for mitochondrial energy production and DNA repair enzymes, declines substantially with age. Nicotinamide riboside reliably raises blood NAD+ in human trials, addressing this specific hallmark directly, though downstream functional aging outcomes beyond raising NAD+ itself are still being actively studied. See our full Nicotinamide Riboside guide.
Spermidine: Autophagy
Spermidine triggers autophagy through hypusination of a specific translation regulator, a cellular process that clears damaged proteins and organelles. A 20-year longitudinal study found high dietary spermidine intake associated with meaningfully lower all-cause mortality, and a small randomized trial found three months of supplementation improved memory in older adults with subjective cognitive decline. That said, large-scale randomized trials with hard longevity endpoints in humans are not yet available, and a 2024 trial testing 40mg/day found only minimal effects on circulating polyamine levels, an important caveat on dosing and expectations. See our full Spermidine guide.
Fisetin: A Senolytic Candidate
Fisetin is under active investigation as a senolytic, a compound that selectively clears senescent "zombie" cells that accumulate with age and secrete inflammatory signals. Clinical trials are ongoing, including one testing fisetin for vascular function in older adults, but this remains an early-stage, actively-researched area rather than a settled, proven intervention. See our full Fisetin guide.
Urolithin A: Mitophagy
Urolithin A triggers mitophagy, clearing damaged mitochondria to make room for healthier ones. Randomized trials in middle-aged and older adults show improved muscle strength and mitochondrial health biomarkers, giving this compound some of the more direct human functional-outcome data in the longevity category. See our full Urolithin A guide.
What the Research Actually Shows
Urolithin A for muscle and mitochondrial biomarkers. Evidence level: Promising. Randomized trials show measurable functional improvements.
NR for raising NAD+. Evidence level: Established for the biomarker; downstream outcomes still emerging.
Spermidine for mortality association. Evidence level: Promising, observational. Strong epidemiological signal, but randomized trials with hard longevity endpoints are still lacking.
Fisetin as a senolytic. Evidence level: Early-stage. Active clinical investigation, not yet a settled intervention.
Safety & Who Should Be Cautious
All four compounds discussed have generally favorable short-to-medium-term safety profiles in available human trials. As with any long-term supplementation strategy targeting aging biology, an evolving research field, checking in with a healthcare provider periodically is reasonable, particularly for older adults managing other medications or health conditions.
ⓘ No single compound addresses every hallmark of aging. A thoughtful approach considers which specific mechanism, energy metabolism, autophagy, senescence, or mitochondrial quality, each addition actually targets.
Frequently Asked Questions
Can any supplement actually slow aging?
No single supplement reverses aging, but several compounds have genuine mechanistic rationale and growing human evidence for supporting specific hallmarks of aging, like energy metabolism, autophagy, or mitochondrial quality.
What is the strongest evidence-based longevity compound right now?
Urolithin A currently has some of the more direct human functional-outcome data (muscle strength, mitochondrial biomarkers) among longevity-focused compounds, though the field overall is still developing.
Does spermidine really reduce mortality risk?
A 20-year observational study found high dietary spermidine intake associated with substantially lower all-cause mortality, but this is observational data, not a randomized trial with hard longevity endpoints, so it should be interpreted as a promising association rather than proof of causation.
What are senolytics and are they proven?
Senolytics are compounds like fisetin that aim to clear senescent "zombie" cells. This remains an early-stage, actively-researched area with ongoing clinical trials rather than a proven, settled intervention.
Should I take all of these compounds together?
Each targets a different mechanism, so combining them has theoretical appeal, but rigorous trials testing these specific combinations together are limited. A healthcare provider can help weigh individual risk factors and goals.
Scientific References
- Singh, A., D'Amico, D., Andreux, P. A., et al. "Urolithin A Improves Muscle Strength, Exercise Performance, and Biomarkers of Mitochondrial Health in a Randomized Trial in Middle-Aged Adults." Cell Reports Medicine, 2022;3(5):100633.
- Kiechl, S., Pechlaner, R., Willeit, P., et al. "Higher Spermidine Intake Is Linked to Lower Mortality: A Prospective Population-Based Study." American Journal of Clinical Nutrition, 2018;108(2):371-380.
- Martens, C. R., Denman, B. A., Mazzo, M. R., et al. "Chronic Nicotinamide Riboside Supplementation Is Well-Tolerated and Elevates NAD+ in Healthy Middle-Aged and Older Adults." Nature Communications, 2018;9:1286.
Disclaimer
This article is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It does not constitute medical advice and is independent of any specific product or brand. Always consult a qualified healthcare provider before beginning any new supplement regimen, particularly if you are managing a medical condition.
